img

Global Chronic Pulmonary Hypertension Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Chronic Pulmonary Hypertension Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Pulmonary hypertension happens when the pressure in the blood vessels leading from the heart to the lungs is too high. With pulmonary hypertension, the blood vessels to the lungs develop an increased amount of muscle in the wall of the blood vessels.
Chronic Pulmonary Hypertension Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chronic Pulmonary Hypertension Treatment market is projected to reach US$ 9038.2 million in 2033, increasing from US$ 6312 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
The chronic pulmonary hypertension drug market is driven by the increasing prevalence of pulmonary hypertension and the growing demand for effective treatment options. Chronic pulmonary hypertension is a progressive and life-threatening condition characterized by high blood pressure in the pulmonary arteries, leading to heart and lung complications. The rise in risk factors such as obesity, cardiovascular diseases, and respiratory disorders contributes to market growth. The development of novel drugs, including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs, has significantly improved patient outcomes and expanded treatment options. However, the market also faces challenges, including the complexity of managing the disease, potential side effects of medications, and the need for personalized treatment approaches. Additionally, the high cost of specialized therapies and the limited understanding of the disease's underlying mechanisms can pose obstacles for both patients and healthcare systems. To succeed, companies must focus on research and development to provide innovative and targeted drug therapies, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective chronic pulmonary hypertension drugs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Chronic Pulmonary Hypertension Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Attgeno
Cereno Scientific
Bial - Portela C S.A
Liquidia Technologies
Bellerophon Therapeutics
AbbVie Therapeutics
Insmed
Altavant Sciences
Lupin
Sun Pharmaceutical
Teva
Segment by Type
Oral
Intravenous/Subcutaneous
Inhalational

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chronic Pulmonary Hypertension Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Chronic Pulmonary Hypertension Treatment introduction, etc. Chronic Pulmonary Hypertension Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Chronic Pulmonary Hypertension Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Chronic Pulmonary Hypertension Treatment
1.1 Chronic Pulmonary Hypertension Treatment Market Overview
1.1.1 Chronic Pulmonary Hypertension Treatment Product Scope
1.1.2 Chronic Pulmonary Hypertension Treatment Market Status and Outlook
1.2 Global Chronic Pulmonary Hypertension Treatment Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Chronic Pulmonary Hypertension Treatment Market Size by Region (2018-2033)
1.4 Global Chronic Pulmonary Hypertension Treatment Historic Market Size by Region (2018-2023)
1.5 Global Chronic Pulmonary Hypertension Treatment Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
1.6.1 North America Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
1.6.2 Europe Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
1.6.3 Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
1.6.4 Latin America Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
1.6.5 Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size (2018-2033)
2 Chronic Pulmonary Hypertension Treatment Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Intravenous/Subcutaneous
2.1.3 Inhalational
2.2 Global Chronic Pulmonary Hypertension Treatment Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Chronic Pulmonary Hypertension Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Type (2018-2033)
3 Chronic Pulmonary Hypertension Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Chronic Pulmonary Hypertension Treatment Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Chronic Pulmonary Hypertension Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue Breakdown by Application (2018-2033)
4 Chronic Pulmonary Hypertension Treatment Competition Analysis by Players
4.1 Global Chronic Pulmonary Hypertension Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Pulmonary Hypertension Treatment as of 2022)
4.3 Date of Key Players Enter into Chronic Pulmonary Hypertension Treatment Market
4.4 Global Top Players Chronic Pulmonary Hypertension Treatment Headquarters and Area Served
4.5 Key Players Chronic Pulmonary Hypertension Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Chronic Pulmonary Hypertension Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.1.4 Bayer Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Attgeno
5.2.1 Attgeno Profile
5.2.2 Attgeno Main Business
5.2.3 Attgeno Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.2.4 Attgeno Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Attgeno Recent Developments
5.3 Cereno Scientific
5.3.1 Cereno Scientific Profile
5.3.2 Cereno Scientific Main Business
5.3.3 Cereno Scientific Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.3.4 Cereno Scientific Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Bial - Portela C S.A Recent Developments
5.4 Bial - Portela C S.A
5.4.1 Bial - Portela C S.A Profile
5.4.2 Bial - Portela C S.A Main Business
5.4.3 Bial - Portela C S.A Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.4.4 Bial - Portela C S.A Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Bial - Portela C S.A Recent Developments
5.5 Liquidia Technologies
5.5.1 Liquidia Technologies Profile
5.5.2 Liquidia Technologies Main Business
5.5.3 Liquidia Technologies Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.5.4 Liquidia Technologies Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Liquidia Technologies Recent Developments
5.6 Bellerophon Therapeutics
5.6.1 Bellerophon Therapeutics Profile
5.6.2 Bellerophon Therapeutics Main Business
5.6.3 Bellerophon Therapeutics Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.6.4 Bellerophon Therapeutics Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Bellerophon Therapeutics Recent Developments
5.7 AbbVie Therapeutics
5.7.1 AbbVie Therapeutics Profile
5.7.2 AbbVie Therapeutics Main Business
5.7.3 AbbVie Therapeutics Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.7.4 AbbVie Therapeutics Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Therapeutics Recent Developments
5.8 Insmed
5.8.1 Insmed Profile
5.8.2 Insmed Main Business
5.8.3 Insmed Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.8.4 Insmed Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Insmed Recent Developments
5.9 Altavant Sciences
5.9.1 Altavant Sciences Profile
5.9.2 Altavant Sciences Main Business
5.9.3 Altavant Sciences Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.9.4 Altavant Sciences Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Altavant Sciences Recent Developments
5.10 Lupin
5.10.1 Lupin Profile
5.10.2 Lupin Main Business
5.10.3 Lupin Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.10.4 Lupin Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Lupin Recent Developments
5.11 Sun Pharmaceutical
5.11.1 Sun Pharmaceutical Profile
5.11.2 Sun Pharmaceutical Main Business
5.11.3 Sun Pharmaceutical Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.11.4 Sun Pharmaceutical Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Sun Pharmaceutical Recent Developments
5.12 Teva
5.12.1 Teva Profile
5.12.2 Teva Main Business
5.12.3 Teva Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
5.12.4 Teva Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Teva Recent Developments
6 North America
6.1 North America Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Chronic Pulmonary Hypertension Treatment Market Dynamics
11.1 Chronic Pulmonary Hypertension Treatment Industry Trends
11.2 Chronic Pulmonary Hypertension Treatment Market Drivers
11.3 Chronic Pulmonary Hypertension Treatment Market Challenges
11.4 Chronic Pulmonary Hypertension Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Chronic Pulmonary Hypertension Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Chronic Pulmonary Hypertension Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Chronic Pulmonary Hypertension Treatment Market Size Share by Region (2018-2023)
Table 4. Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Chronic Pulmonary Hypertension Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Chronic Pulmonary Hypertension Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2024-2033)
Table 11. North America Chronic Pulmonary Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Chronic Pulmonary Hypertension Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Chronic Pulmonary Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Chronic Pulmonary Hypertension Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Chronic Pulmonary Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Chronic Pulmonary Hypertension Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Chronic Pulmonary Hypertension Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Chronic Pulmonary Hypertension Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2024-2033)
Table 26. North America Chronic Pulmonary Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Chronic Pulmonary Hypertension Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Chronic Pulmonary Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Chronic Pulmonary Hypertension Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Chronic Pulmonary Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Chronic Pulmonary Hypertension Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Chronic Pulmonary Hypertension Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Chronic Pulmonary Hypertension Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Pulmonary Hypertension Treatment as of 2022)
Table 39. Date of Key Players Enter into Chronic Pulmonary Hypertension Treatment Market
Table 40. Global Chronic Pulmonary Hypertension Treatment Key Players Headquarters and Area Served
Table 41. Chronic Pulmonary Hypertension Treatment Product Solution and Service
Table 42. Global Chronic Pulmonary Hypertension Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Bayer (2018-2023)
Table 48. Bayer Recent Developments
Table 49. Attgeno Basic Information List
Table 50. Attgeno Description and Business Overview
Table 51. Attgeno Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Attgeno (2018-2023)
Table 53. Attgeno Recent Developments
Table 54. Cereno Scientific Basic Information List
Table 55. Cereno Scientific Description and Business Overview
Table 56. Cereno Scientific Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Cereno Scientific (2018-2023)
Table 58. Cereno Scientific Recent Developments
Table 59. Bial - Portela C S.A Basic Information List
Table 60. Bial - Portela C S.A Description and Business Overview
Table 61. Bial - Portela C S.A Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Bial - Portela C S.A (2018-2023)
Table 63. Bial - Portela C S.A Recent Developments
Table 64. Liquidia Technologies Basic Information List
Table 65. Liquidia Technologies Description and Business Overview
Table 66. Liquidia Technologies Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Liquidia Technologies (2018-2023)
Table 68. Liquidia Technologies Recent Developments
Table 69. Bellerophon Therapeutics Basic Information List
Table 70. Bellerophon Therapeutics Description and Business Overview
Table 71. Bellerophon Therapeutics Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Bellerophon Therapeutics (2018-2023)
Table 73. Bellerophon Therapeutics Recent Developments
Table 74. AbbVie Therapeutics Basic Information List
Table 75. AbbVie Therapeutics Description and Business Overview
Table 76. AbbVie Therapeutics Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of AbbVie Therapeutics (2018-2023)
Table 78. AbbVie Therapeutics Recent Developments
Table 79. Insmed Basic Information List
Table 80. Insmed Description and Business Overview
Table 81. Insmed Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Insmed (2018-2023)
Table 83. Insmed Recent Developments
Table 84. Altavant Sciences Basic Information List
Table 85. Altavant Sciences Description and Business Overview
Table 86. Altavant Sciences Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Altavant Sciences (2018-2023)
Table 88. Altavant Sciences Recent Developments
Table 89. Lupin Basic Information List
Table 90. Lupin Description and Business Overview
Table 91. Lupin Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Lupin (2018-2023)
Table 93. Lupin Recent Developments
Table 94. Sun Pharmaceutical Basic Information List
Table 95. Sun Pharmaceutical Description and Business Overview
Table 96. Sun Pharmaceutical Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Sun Pharmaceutical (2018-2023)
Table 98. Sun Pharmaceutical Recent Developments
Table 99. Teva Basic Information List
Table 100. Teva Description and Business Overview
Table 101. Teva Chronic Pulmonary Hypertension Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Chronic Pulmonary Hypertension Treatment Business of Teva (2018-2023)
Table 103. Teva Recent Developments
Table 104. North America Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America Chronic Pulmonary Hypertension Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 106. Europe Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe Chronic Pulmonary Hypertension Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 108. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 111. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Share by Region (2018-2023)
Table 112. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Share by Region (2024-2033)
Table 113. Latin America Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Latin America Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America Chronic Pulmonary Hypertension Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 116. Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 117. Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 119. Chronic Pulmonary Hypertension Treatment Market Trends
Table 120. Chronic Pulmonary Hypertension Treatment Market Drivers
Table 121. Chronic Pulmonary Hypertension Treatment Market Challenges
Table 122. Chronic Pulmonary Hypertension Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Pulmonary Hypertension Treatment Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Chronic Pulmonary Hypertension Treatment Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Chronic Pulmonary Hypertension Treatment Market Share by Regions: 2022 VS 2033
Figure 4. Global Chronic Pulmonary Hypertension Treatment Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Oral
Figure 11. Global Oral Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Intravenous/Subcutaneous
Figure 13. Global Intravenous/Subcutaneous Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Inhalational
Figure 15. Global Inhalational Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Chronic Pulmonary Hypertension Treatment Market Size Share by Type: 2022 & 2033
Figure 17. North America Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2033)
Figure 18. Europe Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue Market Share by Type (2018-2033)
Figure 22. Hospital Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Online Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Chronic Pulmonary Hypertension Treatment Market Size Share by Application: 2022 & 2033
Figure 26. North America Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2033)
Figure 27. Europe Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Chronic Pulmonary Hypertension Treatment Revenue Market Share by Application (2018-2033)
Figure 31. Chronic Pulmonary Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Chronic Pulmonary Hypertension Treatment Market Share in 2022
Figure 33. North America Chronic Pulmonary Hypertension Treatment Market Share by Country (2018-2033)
Figure 34. United States Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 37. France Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Chronic Pulmonary Hypertension Treatment Market Share by Region (2018-2033)
Figure 43. China Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 47. India Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Chronic Pulmonary Hypertension Treatment Market Share by Country (2018-2033)
Figure 50. Mexico Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Chronic Pulmonary Hypertension Treatment Market Share by Country (2018-2033)
Figure 53. Turkey Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Chronic Pulmonary Hypertension Treatment Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries